| July 2024Updates from the National Institutes of Health (NIH) Office of Disease Prevention (ODP) including upcoming events, funding opportunities, and resources to help you conduct high-quality prevention research.
We want this information to be valuable to you, so please send your feedback and suggestions to [email protected].
|
|
Building Relationships with Mentors: Advice from Future Leaders in Prevention Science |
|
Every year, the ODP Early Stage Investigator Lecture (ESIL) recognizes early career scientists who are poised to become leaders in prevention research. Creating a network of mentors who provide different insights and guidance is an important part of becoming a successful investigator. Our three 2024 ESIL awardees shared advice for finding and building fulfilling relationships with a team of mentors. |
|
|
New Methodological Resources and Sample Size Calculator for Group or Cluster Regression Discontinuity DesignsThe NIH Research Methods Resources (RMR) website, managed by ODP, now includes information to help you use group or cluster regression discontinuity designs (GRDDs) in your studies. GRDDs can be used to evaluate interventions delivered in a group format where it is difficult to implement a randomized trial (for example, within a clinical practice or public health program). Most methods developed for these designs have been in the areas of education or econometrics, but their use in public health, epidemiology, and health care research has been suggested, as observational data are commonplace in these settings. The RMR website provides background material and references on how to use GRDDs, as well as a new sample size calculator. In addition to GRDDs, the RMR website features materials and sample size calculators for parallel group- or cluster-randomized trials, individually randomized group-treatment trials, and stepped wedge group- or cluster-randomized trials. NIH funding opportunities that may involve trials that randomize and/or deliver interventions to groups often encourage investigators to use the information, references, and four custom-built sample size calculators on the RMR site when developing their research applications.
Tracking NIH Research Activities Related to Clinical Preventive Service Research GapsEach year, ODP conducts the I Statement Reporting Survey to collect information about current NIH activities that address research needs and gaps in U.S. Preventive Services Task Force (USPSTF) insufficient evidence (I) statements. The results from the 2023 survey are now available. Researchers can use the survey results to review NIH activities related to addressing the I statements and identify opportunities for investigator-initiated activities. The USPSTF is an independent panel of experts that makes evidence-based recommendations about clinical preventive services such as screenings, counseling, and preventive medications. The USPSTF publishes I statements when it is not possible to make a recommendation about the benefits or harms of a service because the scientific evidence is lacking, of poor quality, or conflicting. NIH’s long-standing partnership with the USPSTF has been instrumental in strengthening the evidence base for preventive services, generating new evidence that has helped change I statements to graded recommendations for or against the preventive service. |
|
|
Prevention Research Funding Opportunities |
|
|
National Strategy for Suicide Prevention U.S. Department of Health and Human Services A 10-year, comprehensive, whole-of-society approach to suicide prevention that provides concrete recommendations for addressing gaps in the suicide prevention field through four Strategic Directions. Melanoma Dashboard Centers for Disease Control and Prevention (CDC) Melanoma causes the most deaths among all types of skin cancer, and incidence rates have increased over time. CDC’s Melanoma Dashboard provides a wide range of relevant state and local data to help communities better meet their unique melanoma prevention needs. Prevention TaskForce U.S. Preventive Services Task Force (USPSTF) The Prevention TaskForce (formerly ePSS) application assists primary care clinicians to identify the screening, counseling, and preventive medication services that are appropriate for their patients. The Prevention TaskForce data are based on the current recommendations of the USPSTF. |
|
Recent WebinarsEarly Stage Investigator Lectures Methods: Mind the Gap Webinar Series Prevention in Focus Webinar Series In Their Own Words: ODP’s Youth Art Challenge Awardees | | What do young people have to say about prevention and health equity? Hear from our ODP Art Challenge awardees in this new video where they share insights on why they chose their topics and how they created their artwork. |
NIH Office of Research on Women’s Health Hosts Menopause Roundtable |
|
Researchers Review Findings and Clinical Messages from the Women’s Health InitiativeA new review in JAMA highlights key findings and clinical messages from the Women’s Health Initiative (WHI), the largest women’s health study in the United States. In the review, researchers explain the primary findings from the long-term WHI data related to hormone therapy and chronic conditions, calcium and vitamin D supplements and bone fractures, and low-fat diets and cancer. Data from this influential study underscore the importance of personalized and shared decision-making to support the health of postmenopausal women. The WHI was created to study factors that may reduce risks for cardiovascular disease, cancer, hip fractures, and other conditions in postmenopausal women. More than 68,000 women enrolled in clinical trials between 1993 and 1998 and were followed for up to 20 years. Initial planning for the WHI began in 1991 under the leadership of ODP Director Dr. William R. Harlan before the study was transferred to the National Heart, Lung, and Blood Institute in 1996, where it is still supported. NIH Releases Draft Public Access Policy and Draft Supplemental Guidance for Public FeedbackNIH is seeking public comments on the draft of its updated Public Access Policy in support of its mission to advance access to NIH-funded research results, as well as two supplemental draft guidance documents regarding government-use license and rights and costs for publications. The draft Public Access Policy, which builds on NIH’s long history of providing public access to scholarly publications resulting from the research it supports, outlines how NIH proposes to address the Administration’s 2022 Memo on Ensuring Free, Immediate, and Equitable Access to Federally Funded Research (PDF) through additional steps to accelerate access. Additionally, NIH is proposing supplementary draft guidance on government-use license and rights and publication costs to assist the community with implementing the proposal. Communities Advancing Research Equity for Health™ ProgramNIH is proposing to establish Communities Advancing Research Equity for Health™ (CARE for Health™), a network to conduct research in primary care settings. This network will address barriers to access to clinical research participation by implementing a sustained infrastructure that integrates innovative research with routine clinical care in real-world settings, with a focus on sustained engagement with communities that are traditionally underrepresented in clinical research. Improving access to clinical studies will facilitate and accelerate research advances for adoption and implementation into everyday clinical care, improving health outcomes and advancing health equity for all Americans. |
|
Staff PublicationsAdult obesity treatment and prevention: A trans-agency commentary on the research landscape, gaps, and future opportunities Hoffman RK, Donze L, Agurs-Collins T, Belay B, Berrigan D, Blanck HM, Brandau A, Chue A, Czajkowski S, Dillon G, Kompaniyets L, Kowtha B, Li R, Mujuru P, Mudd L, Nebeling L, Tomoyasu N, Young-Hyman D, Zheng X, Pratt C. Obesity Reviews. 2024 June 03; e13769. doi: 10.1111/obr.13769. PMID: 38830619. Characteristics of Adolescents’ and Young Adults’ Exposure to and Engagement with Nicotine and Tobacco Product Content on Social Media Vogel EA, Ranker LR, Harrell PT, Hart JL, Kong G, McIntosh S, Meissner HI, Ozga JE, Romer D, Stanton CA. Journal of Health Communication. 2024; 29(6):383–393. doi: 10.1080/10810730.2024.2355291. PMID: 38775659. |
|
| |
|